IDEXX's Big Bet on AI: Will It Pay Off for Vets and Investors? IDEXX Laboratories' recent acquisition of CoVetAI has left many in the veterinary community wondering what this means for their daily work.
On its surface, CoVetAI's software appears to be just another productivity tool – it listens to vet patient conversations and organizes notes into actionable insights.
However, beneath the surface lies a complex web of motivations, including driving sales growth and expanding market reach.